Mizuho Americas
News
Obesity drug supply-demand imbalance is working in Novo Nordisk’s favor: Mizuho’s Jared Holz

Obesity drug supply-demand imbalance is working in Novo Nordisk’s favor: Mizuho’s Jared Holz

February 1, 2024
Obesity drug supply-demand imbalance is working in Novo Nordisk’s favor: Mizuho’s Jared HolzObesity drug supply-demand imbalance is working in Novo Nordisk’s favor: Mizuho’s Jared Holz

Jared Holz, Mizuho Securities, joins ‘Fast Money’ to talk demand in the obesity drug space and who is benefiting from the supply-demand imbalance.

Share This

Latest Mizuho News

See all news
Mizuho Americas announces $1 million in grants through the Mizuho USA Foundation

Mizuho Americas announces $1 million in grants through the Mizuho USA Foundation

January 5, 2026
Nvidia is the most compelling tech stock you can buy right now, says Mizuho’s Jordan Klein

Nvidia is the most compelling tech stock you can buy right now, says Mizuho’s Jordan Klein

November 18, 2025
VR has been ‘pretty big disappointment’ for Meta, says Mizuho’s Lloyd Walmsley

VR has been ‘pretty big disappointment’ for Meta, says Mizuho’s Lloyd Walmsley

December 4, 2025

Mizuho news from around the globe

 Mizuho Global News
back-to-top-blue